Carmignac Gestion Surmodics Inc Transaction History
Carmignac Gestion
- $5.82 Billion
- Q3 2024
A detailed history of Carmignac Gestion transactions in Surmodics Inc stock. As of the latest transaction made, Carmignac Gestion holds 73,094 shares of SRDX stock, worth $2.49 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
73,094Holding current value
$2.49 Million% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding SRDX
# of Institutions
128Shares Held
11.8MCall Options Held
1.4KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$39.9 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$35.4 Million0.01% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA989KShares$33.7 Million14.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$27.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY753KShares$25.6 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $477M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...